💊
Acvybra
denosumab
Resorpcja kostna;Osteoporoza;Osteoporoza pomenopauzalna
✅ Upoważniony
Biosimilar
✅
Brak aktywnych alertów
Ten lek nie jest objęty bieżącymi niedoborami, listami ostrzegawczymi ani wycofany z rynku.
Do czego to służy
Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women Acvybra significantly reduces the risk of vertebral, non-vertebral and hip fractures.Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. In men with prostate cancer receiving hormone ablation, Acvybra significantly reduces the risk of vertebral fractures.Treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture.
⚠️ Bezpieczeństwo pacjenta
No
Oficjalna strona EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/acvybra